← All CCP Flashcard Decks

Federal and State Regulations Flashcards

7 cards from real CCP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Federal and State Regulations flashcards as text
  1. Under the Combat Methamphetamine Epidemic Act (CMEA), what is the daily sales limit for pseudoephedrine products per purchaser?

    Answer: 3.6 grams

    CMEA limits pseudoephedrine sales to 3.6 grams per day per purchaser, with a 30-day limit of 9 grams.

  2. Which DEA form must be completed when a pharmacy discovers a significant theft or loss of controlled substances?

    Answer: DEA Form 106

    DEA Form 106 (Report of Theft or Significant Loss of Controlled Substances) must be filed when significant theft or loss occurs.

  3. A long-term care pharmacy receives an order for a Schedule II controlled substance via fax. Under federal law, what must happen before the drug can be dispensed?

    Answer: The original written prescription must be presented before dispensing

    Schedule II prescriptions transmitted by fax to LTC pharmacies serve only as the original written Rx; the original must be presented before dispensing.

  4. Which federal agency is responsible for enforcing the Omnibus Budget Reconciliation Act (OBRA '90) prospective drug utilization review requirements?

    Answer: CMS (Centers for Medicare & Medicaid Services)

    CMS oversees OBRA '90 compliance for Medicaid programs, including prospective DUR requirements.

  5. A pharmacist working in a long-term care setting must perform a Medication Regimen Review (MRR) for each resident at minimum:

    Answer: Every 30 days

    Federal regulations (42 CFR 483.45) require a consultant pharmacist to conduct an MRR for each LTC resident at least monthly.

  6. Under HIPAA, a pharmacy may share protected health information (PHI) with a patient's family member without explicit patient authorization when:

    Answer: The patient is present and does not object

    HIPAA allows disclosure to a family member involved in the patient's care when the patient is present and has the opportunity to agree or object and does not object.

  7. Which provision of the Medicare Modernization Act (MMA) of 2003 specifically created requirements for Medication Therapy Management (MTM) services?

    Answer: Section 1860D-4(c) — Part D MTM programs

    Section 1860D-4(c) of the MMA mandated that Part D prescription drug plans offer MTM programs to targeted beneficiaries.